A Single Center Registry of Coronary OCT

Sponsor
Hainan People's Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04855500
Collaborator
(none)
200
1
37
5.4

Study Details

Study Description

Brief Summary

This registry started January 1,2020 to collect patients who recieve coronary OCT imaging in Hainan General Hospital.All enrolled patients will receive 1 year followed-up.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This registry started January 1,2020.Patients >= 18 years old who recieve coronary OCT imaging in Hainan General Hospital are included in current registry.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    200 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    A Registry of Coronary Artery Optical Coherence Tomography of Hainan General Hospital
    Actual Study Start Date :
    Jan 1, 2020
    Anticipated Primary Completion Date :
    Dec 31, 2022
    Anticipated Study Completion Date :
    Jan 31, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Major adverse cardiac events (MACE) [1 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Subjects who recieved intracoronary OCT imaging during cardiac catheterization are eligible for this registry.
    Exclusion Criteria:
    • None

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hainan General Hospital Haikou Hainan China 570311

    Sponsors and Collaborators

    • Hainan People's Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Liao Wang, Deputy director of Cardiology, Hainan People's Hospital
    ClinicalTrials.gov Identifier:
    NCT04855500
    Other Study ID Numbers:
    • WangLiao002
    First Posted:
    Apr 22, 2021
    Last Update Posted:
    Apr 22, 2021
    Last Verified:
    Apr 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 22, 2021